Banner Graphic
We are excited to announce that AskElephant is now part of the Fullcast product suite!
Read more
Banner Graphic
The Revenue Roadshow is coming to a city near you!
Save your seat

What Is Deal Aging? (And Why It’s Killing Your Win Rates)

Sep 14, 2026

Amy Cook

Win more with Fullcast

deal aging featured image

Your pipeline has a quiet problem. Deals that should have closed weeks ago are still sitting in your forecast, dragging down win rates, distorting projections, and consuming selling capacity that could be spent on winnable opportunities. Sales cycles lengthened 22% since 2022, with the median B2B sales cycle now at 84 days. That extended timeline has made deal aging worse than ever.

Deal aging measures opportunities that remain in the sales pipeline longer than the average sales cycle for similar deals. Simple concept. Massive impact. Aging deals close at lower rates, create phantom pipeline that inflates forecasts, and waste rep time on opportunities that will never convert.

The good news is that deal aging is measurable, predictable, and fixable.

What follows is a breakdown of exactly what deal aging is, why it happens, and how to identify it before it becomes a problem.

Key Takeaways

1. What is deal aging in sales?
Deal aging measures how long an opportunity has remained in the pipeline compared with the normal sales cycle for similar deals. Teams should consider both the total age of the opportunity and the amount of time it has spent in its current stage.

2. How does deal aging affect win rates and forecast accuracy?
The longer deals remain open without meaningful progression, the less likely they are to close. Fullcast’s benchmarks show deals closed within 30 days at 1.9x the baseline win rate, while deals open 181–360 days fall to 0.7x and those exceeding a year fall to 0.6x. Aging opportunities also create “phantom pipeline” that can inflate forecasts without producing revenue.

3. Why do sales deals get stuck in the pipeline?
Common causes include weak initial qualification, disengaged economic buyers or champions, budget and timing problems, procurement and legal delays, rep reluctance to close-lost an opportunity, and deals without a defined next step.

4. How do you identify and manage aging sales opportunities?
Start by establishing normal sales-cycle lengths by segment, deal size, and product. Compare both days in pipeline and days in stage, establish clear aging thresholds, add activity and engagement signals, and regularly review flagged opportunities. The article suggests 1.5x the normal cycle as a possible “watch” threshold and 2x as “at risk.”

You will walk away with the data behind win rate decline as deals age, the root causes that stall opportunities, a step-by-step framework for diagnosing aging deals in your pipeline, and a clear decision model for what to do once you find them.

What Is Deal Aging? A Clear Definition

Deal aging measures how long an opportunity has been in your sales pipeline, counted in days from opportunity creation to either the current date or the close date.

At its simplest, deal aging answers one question: how old is this deal relative to how old it should be?

Every sales organization has an average sales cycle length. It varies by segment, deal size, and product line. Deal aging becomes actionable when you compare an individual deal’s age against that baseline. If your average sales cycle is 60 days and a deal has been open for 90, that deal is aging and needs intervention.

But deal aging is not just about old deals. It is about deals that are too old for their stage. A deal sitting in the discovery stage at day 45 when most deals move to evaluation by day 20 is aging, even if it has not yet exceeded the total average cycle length. This stage-level view separates useful deal aging analysis from simple calendar math.

Deal aging predicts deal health and win probability better than almost any other metric. The longer a deal lingers without progression, the less likely it is to close.

Why Deal Aging Matters: The Data Behind the Decline

Managing deal aging is not optional. The data shows that aging deals drain resources and destroy forecast accuracy.

According to Fullcast’s 2026 GTM Benchmarks Report, lost deals take 2.0x longer to close than won deals. That gap represents months of wasted selling capacity, forecasting noise, and pipeline coverage that exists on paper but will never convert.

“Lost deals take 2.0x longer to close than won deals. That gap isn’t just wasted time. It’s months of selling capacity, forecasting noise, and pipeline coverage that exists on paper but will never convert. Reps hold deals because dropping them feels like admitting failure… Every day spent on a deal past its inflection point isn’t just unproductive. It’s actively expensive.”

The win rate decline by deal age tells the story in stark terms:

  • 1 to 30 days: 1.9x baseline win rate
  • 31 to 60 days: 1.2x baseline win rate
  • 61 to 180 days: 1.0x baseline win rate
  • 181 to 360 days: 0.7x baseline win rate
  • 361+ days: 0.6x baseline win rate

The pattern is unmistakable. Deals that close quickly win at nearly double the baseline rate. Deals that linger past six months win at less than three-quarters of the baseline. Deals that stretch past a year are more likely to lose than win.

The forecasting problem is equally damaging. Aging deals create “phantom pipeline,” which is a collection of opportunities that appear in commit forecasts but will never convert. This inflates projections, misleads leadership, and makes it nearly impossible to predict revenue accurately. Reps who cannot identify and exit aging deals miss quota because they spend time on the wrong opportunities.

The Root Causes: Why Deals Age in the First Place

Deals age for identifiable, systemic reasons. Fix the root causes and you fix the aging problem.

Opportunities stall in predictable patterns. Understanding these root causes requires a systematic way to score deal health across multiple dimensions.

Deals That Were Never Qualified Properly

Deals that were never a strong fit from the start are the most common source of aging. When qualification criteria are loose or inconsistent, weak opportunities enter the pipeline and linger because there was never genuine buying intent.

The Economic Buyer Has Gone Silent

Deals stall when the economic buyer or internal champion is not actively engaged. Without someone inside the buying organization pushing the deal forward, momentum dies. Ask yourself: when did you last hear from your champion?

Budget Exists But Timing Does Not

The customer may have genuine interest but no approved budget or no urgency to act. These deals sit in limbo, aging quietly while reps hold on hoping for a change in circumstances.

Procurement and Legal Bottlenecks

Legal reviews, procurement cycles, and technical evaluations create bottlenecks that are often outside the rep’s control. These delays are predictable in enterprise sales but still contribute to aging if not accounted for in cycle length benchmarks.

Reps Refuse to Let Go

Reps are often reluctant to mark a deal as closed-lost because it feels like admitting failure and hurts their pipeline coverage metrics. This creates an incentive to keep aging deals alive on paper long after they have effectively died.

No Clear Next Step Exists

Deals without clear next steps, defined decision criteria, or recent activity are aging by default. If no one is actively working the deal, it is not progressing.

How to Identify Aging Deals in Your Pipeline

Revenue teams need a repeatable process for surfacing aging deals before they distort the forecast. Use this five-step framework.

Step 1: Establish Your Baseline Average Sales Cycle Length

Calculate your average sales cycle by deal size, segment, and product line. A single company-wide average is too blunt. SMB deals typically close in 30 to 60 days, while enterprise deals may take 6 to 12 months. Your aging thresholds must reflect these differences.

Step 2: Segment Your Pipeline by Days in Stage and Days in Pipeline

Look at both total deal age and how long each deal has been in its current stage. A deal that is 90 days old but just entered negotiation last week is different from a deal that has been stuck in discovery for 90 days.

Step 3: Create Aging Thresholds

Define clear thresholds based on multiples of your average cycle. For example, 1.5x the average equals a “watch” status. 2x the average equals “at risk.” These thresholds give pipeline reviews a common language and clear triggers for action.

Step 4: Layer in Activity and Engagement Data

Deals with low activity and high age represent the highest risk. Look for patterns: no emails exchanged in 14 days, no meetings scheduled, no stakeholder responses. Modern revenue teams are turning to AI deal health scoring to automatically flag aging deals based on activity, engagement, and relationship patterns.

Step 5: Review Aging Deals With a “Close or Close-Lost” Mindset

Make aging deal reviews a standing agenda item in pipeline meetings. The question for every flagged deal should be direct: what specific evidence suggests this deal will close, and by when? If the answer is vague, it is time to make a decision.

While deal aging is a critical individual deal metric, it also impacts your overall pipeline health and forecast accuracy. Addressing aging deals at the individual level creates compounding improvements across the entire pipeline.

Take Control of Deal Aging With Fullcast

Every day a deal sits past its inflection point costs you money, rep time, and forecast accuracy.

Reps spend less than 15% of their time on deals that generate revenue, according to Salesforce research. Aging deals are a primary reason why.

Fixing this problem across your entire pipeline requires systems that diagnose deal health across every opportunity, not just the ones that are obviously stalling.

Fullcast Revenue Intelligence helps revenue teams improve seller quota attainment and forecast accuracy within 10% of target. The platform analyzes activity, coverage, and engagement to spot pipeline risk before deals go cold. Your team gets the information to act early and act decisively.

Beyond deal health, Fullcast’s Performance-to-Plan Tracking helps you monitor KPIs, identify plan drift, and take corrective action before targets are missed.

Your aging deals are costing you more than you realize. Request a demo or explore Fullcast Revenue Intelligence to see how your team can close the right deals, forecast with confidence, and hit quota consistently.

FAQ

1. What is deal aging in sales?

Deal aging measures how long an opportunity has been in your sales pipeline, counted in days from creation to either the current date for open deals or the close date for closed deals. It becomes meaningful when comparing an individual deal’s age against your baseline average sales cycle length.

2. Why do aging deals hurt sales performance?

Aging deals drag down win rates, distort revenue projections, and consume valuable selling capacity that could be spent on higher-probability opportunities. Research consistently shows that deal close probability decreases as time in pipeline increases beyond the average sales cycle.

3. What is phantom pipeline?

Phantom pipeline refers to aging opportunities that appear in commit forecasts but will never actually convert. These deals inflate projections and mislead leadership about true revenue potential, creating significant forecasting problems.

4. What causes deals to age in the first place?

Six primary factors cause deal aging:

  • Misqualification of weak opportunities
  • Lack of stakeholder engagement
  • Budget and timing misalignment
  • Internal process delays like legal or procurement reviews
  • Rep reluctance to close-lost deals
  • Poor deal hygiene with no clear next steps

5. How do you identify which deals are aging?

Follow these steps to identify aging deals:

  1. Establish your baseline average sales cycle by segment and product
  2. Segment your pipeline by days in stage and total days open
  3. Create aging thresholds where deals at one-and-a-half times your average are flagged as watch items
  4. Mark deals at double your average as at risk

6. Why do sales reps hold onto aging deals instead of closing them out?

Reps often hold deals because dropping them feels like admitting failure. This avoidance behavior keeps low-probability opportunities in the pipeline, consuming time and resources while distorting forecasts and pipeline coverage.

7. How should you handle deals that have exceeded your average sales cycle?

Handle aging deals by following these steps:

  1. Review each deal with a close-or-close-lost mindset
  2. Layer in activity and engagement data to assess whether genuine buyer interest exists
  3. Make a definitive decision rather than letting the deal continue consuming resources

8. Can deal aging be fixed?

Deal aging is measurable, predictable, and fixable through proper diagnosis and clear thresholds. Revenue intelligence tools can help spot aging risk early, allowing teams to intervene before opportunities become unrecoverable.

9. How does deal aging affect sales rep productivity?

Sales reps often find that aging deals consume significant time that could be spent on higher-probability opportunities. Every day spent on a deal past its inflection point is actively expensive, not just unproductive.

Amy Cook

Amy Osmond Cook, Ph.D., is a seasoned marketing executive and communications expert, recognized for her innovative strategies in technology, healthcare and real estate marketing. She is the co-founder and Chief Marketing Officer of Fullcast, the Go-to-Market Cloud, and has a proven track record helping multiple high-growth companies move from series A through acquisition (Simplus, 2020; PathologyWatch, 2023; Onboard, 2024). Amy founded and led Stage Marketing as CEO for 15 years, building it into a leading full-funnel marketing firm. With a Ph.D. in Communication from the University of Utah, Amy has authored numerous articles and served as a prominent voice in business and healthcare communities. Her passion for empowering others is evident in her work and community involvement. She and her husband, Jeff, have five children.